Stepholidine

千金藤啶碱

Report date: 2022/01/14 13:23:58

Base Information

Drug NameStepholidine
Drug Alias Name千金藤定碱光千金藤定碱
ClassificationSmall molecules
Mechanisms of ActionDopamine D1 receptor antagonistsDopamine D2 receptor antagonists
TargetsDopamine D1 receptorDopamine D2 receptor
Therapy Area/IndicationsAttention Deficit Disorder with HyperactivityHeadacheMigraine Disorders +[4] 
Global Approved IndicationsAttention Deficit Disorder with HyperactivityHeadacheMigraine Disorders +[4] 
Approved Indications in ChinaAttention Deficit Disorder with HyperactivityHeadacheMigraine Disorders +[4] 
Original Approved Country/TerritoryMainland China
Original Approved Date1995/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsAttention Deficit Disorder with HyperactivityHeadacheMigraine Disorders +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A